FDA Inspection 1088395 — Qilu Pharmaceutical Co., Ltd.
The FDA completed an inspection of Qilu Pharmaceutical Co., Ltd. on February 22, 2019 in Jinan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 22, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinan (China)